Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions.

hypoxia lung cancer renin-angiotensin tumor microenvironment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
03 Jun 2020
Historique:
received: 16 04 2020
revised: 24 05 2020
accepted: 01 06 2020
entrez: 7 6 2020
pubmed: 7 6 2020
medline: 7 6 2020
Statut: epublish

Résumé

The mechanistic involvement of the renin-angiotensin system (RAS) reaches beyond cardiovascular physiopathology. Recent knowledge pinpoints a pleiotropic role for this system, particularly in the lung, and mainly through locally regulated alternative molecules and secondary pathways. Angiotensin peptides play a role in cell proliferation, immunoinflammatory response, hypoxia and angiogenesis, which are critical biological processes in lung cancer. This manuscript reviews the literature supporting a role for the renin-angiotensin system in the lung tumor microenvironment and discusses whether blockade of this pathway in clinical settings may serve as an adjuvant therapy in lung cancer.

Identifiants

pubmed: 32503281
pii: cancers12061457
doi: 10.3390/cancers12061457
pmc: PMC7352181
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Am J Cancer Res. 2017 May 01;7(5):1016-1036
pubmed: 28560055
Am J Physiol Renal Physiol. 2011 Mar;300(3):F700-6
pubmed: 21209001
Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1219-30
pubmed: 22227126
World J Biol Chem. 2015 Aug 26;6(3):209-17
pubmed: 26322175
Shock. 2013 Nov;40(5):420-9
pubmed: 23903854
J Hypertens. 2001 Mar;19(3 Pt 2):553-9
pubmed: 11327629
Cancer Res. 2010 Nov 1;70(21):8319-28
pubmed: 20837666
PLoS One. 2012;7(4):e35667
pubmed: 22536420
Cancer Res. 2007 Mar 15;67(6):2809-15
pubmed: 17363603
Anticancer Res. 2019 Sep;39(9):4597-4602
pubmed: 31519556
Genet Mol Res. 2014 Dec 12;13(4):10562-73
pubmed: 25511041
Clin Cancer Res. 2009 Dec 1;15(23):7398-404
pubmed: 19920106
Int J Cancer. 2010 Nov 15;127(10):2279-91
pubmed: 20143398
J Renin Angiotensin Aldosterone Syst. 2015 Mar;16(1):189-94
pubmed: 25354524
Lab Invest. 2014 May;94(5):536-44
pubmed: 24614194
Endocrinology. 2003 Jun;144(6):2179-83
pubmed: 12746271
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
J Cancer Res Clin Oncol. 2009 Oct;135(10):1429-35
pubmed: 19399518
J Am Coll Cardiol. 2016 Aug 9;68(6):639-653
pubmed: 27491909
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696
pubmed: 30395904
J Biol Chem. 2000 Sep 1;275(35):26765-71
pubmed: 10837481
Curr Pharm Des. 2012;18(7):963-70
pubmed: 22283774
Lung. 2012 Oct;190(5):523-7
pubmed: 22810758
Physiol Rev. 2018 Jan 1;98(1):505-553
pubmed: 29351514
Pulm Med. 2012;2012:315918
pubmed: 22900168
Blood Press. 2003;12(2):70-88
pubmed: 12797627
J Pharmacol Sci. 2010;113(4):301-9
pubmed: 20675958
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L143-51
pubmed: 10893213
J Pathol. 2000 Nov;192(3):379-84
pubmed: 11054722
Lung Cancer. 2015 Nov;90(2):121-7
pubmed: 26363803
Nat Med. 1998 Jan;4(1):50-7
pubmed: 9427606
Am J Respir Crit Care Med. 2012 Oct 15;186(8):780-9
pubmed: 22859525
Cytokine Growth Factor Rev. 2014 Aug;25(4):423-35
pubmed: 25156420
Cancers (Basel). 2018 Jun 11;10(6):
pubmed: 29891791
Circ Res. 2018 Jan 19;122(2):319-336
pubmed: 29348253
Sci Transl Med. 2017 Oct 4;9(410):
pubmed: 28978752
Curr Hypertens Rep. 2012 Apr;14(2):160-9
pubmed: 22302531
Inflamm Res. 2013 Feb;62(2):219-28
pubmed: 23233095
Cancer Lett. 2016 Jul 1;376(2):268-77
pubmed: 27063099
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):768-73
pubmed: 26438582
J Signal Transduct. 2011;2011:821615
pubmed: 21637381
PLoS One. 2012;7(5):e37750
pubmed: 22662209
Differentiation. 2002 Dec;70(9-10):498-505
pubmed: 12492492
Oncol Lett. 2017 Sep;14(3):3193-3198
pubmed: 28927065
Curr Med Chem. 2011;18(23):3506-15
pubmed: 21756232
Int J Oncol. 2014 Jun;44(6):1806-12
pubmed: 24691919
Histochem Cell Biol. 2001 Feb;115(2):117-24
pubmed: 11444146
Endokrynol Pol. 2011;62(2):151-8
pubmed: 21528478
Curr Cancer Drug Targets. 2011 May;11(4):394-404
pubmed: 21395552
Int J Oncol. 2010 Nov;37(5):1251-9
pubmed: 20878072
Curr Pharm Des. 2003;9(9):715-22
pubmed: 12570789
BMJ. 2018 Oct 24;363:k4209
pubmed: 30355745
Curr Pharm Des. 2007;13(13):1307-16
pubmed: 17506716
J Pathol. 2004 Mar;202(3):330-5
pubmed: 14991898
Trends Pharmacol Sci. 2008 Jul;29(7):367-74
pubmed: 18579222
Ann Oncol. 2016 Aug;27(8):1492-504
pubmed: 27207108
Int J Biochem Cell Biol. 2012 Mar;44(3):465-8
pubmed: 22155301
Mol Cancer Ther. 2009 Dec;8(12):3255-65
pubmed: 19996275
Semin Oncol. 2001 Apr;28(2 Suppl 8):29-35
pubmed: 11395850
Aging (Albany NY). 2019 Jun 19;11(12):3969-3992
pubmed: 31219799
Hypertension. 2010 Jan;55(1):153-60
pubmed: 19996065
Br J Pharmacol. 2003 May;139(1):81-8
pubmed: 12746226
Biomed Res Int. 2014;2014:627380
pubmed: 25401104
Nat Med. 2003 Jul;9(7):936-43
pubmed: 12796773
Exp Physiol. 2012 Jan;97(1):89-101
pubmed: 21967903
Am J Cardiovasc Drugs. 2016 Oct;16(5):309-21
pubmed: 27260014
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14109-14114
pubmed: 27872279
J Biol Chem. 2002 Apr 26;277(17):14838-43
pubmed: 11815627
Pharmacotherapy. 2005 Sep;25(9):1213-29
pubmed: 16164395
J Biol Chem. 2006 May 12;281(19):13209-16
pubmed: 16543233
BMC Cell Biol. 2010 May 26;11:36
pubmed: 20500895
J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):227-33
pubmed: 23934336
Am J Hum Genet. 1992 Jul;51(1):197-205
pubmed: 1319114
Cardiovasc Res. 2004 Aug 15;63(3):433-42
pubmed: 15276468
Cancer Sci. 2018 Jan;109(1):54-64
pubmed: 29034589
Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15
pubmed: 18402527
Eur Respir J. 2008 Oct;32(4):1004-8
pubmed: 18508830
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63
pubmed: 12829792
Oncotarget. 2018 Oct 26;9(84):35500-35511
pubmed: 30464806
FASEB J. 2007 Oct;21(12):3240-9
pubmed: 17504975
Oncol Rep. 2010 Apr;23(4):941-8
pubmed: 20204277
J Biol Chem. 2002 Dec 13;277(50):48403-9
pubmed: 12379645
Regul Pept. 1992 Aug 13;40(3):409-19
pubmed: 1438983
Int J Oncol. 2016 Sep;49(3):857-67
pubmed: 27573431
BMC Cancer. 2012 Sep 11;12:404
pubmed: 22963500
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2281-90
pubmed: 16055515
J Pathol. 2011 Dec;225(4):618-27
pubmed: 22009550
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
J Diabetes Metab. 2015 Oct 14;6(10):
pubmed: 26793405
Clin Exp Immunol. 2012 Feb;167(2):195-205
pubmed: 22235995
Nat Rev Cancer. 2010 Nov;10(11):745-59
pubmed: 20966920
Sci Rep. 2016 Feb 17;6:21359
pubmed: 26883083
Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1275-84
pubmed: 16115033
Eur Respir J. 2015 Oct;46(4):1084-94
pubmed: 26113671
Mol Cancer Ther. 2016 Jan;15(1):37-47
pubmed: 26671566
Int Immunol. 2016 Aug;28(8):393-9
pubmed: 27401477
Cell Mol Neurobiol. 2009 Sep;29(6-7):781-92
pubmed: 19259805
Adv Exp Med Biol. 2014;816:1-23
pubmed: 24818717
Oncol Rep. 2016 Sep;36(3):1403-10
pubmed: 27460845
Anticancer Res. 2015 Sep;35(9):4789-97
pubmed: 26254369
FASEB J. 2009 Jun;23(6):1655-62
pubmed: 19211927
Carcinogenesis. 2008 Sep;29(9):1675-84
pubmed: 18632755
Blood Press Suppl. 1996;2:47-52
pubmed: 8913540
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2909-14
pubmed: 21282607
J Renin Angiotensin Aldosterone Syst. 2015 Mar;16(1):219-26
pubmed: 23676252
Cancer Res. 2007 Jul 1;67(13):6520-7
pubmed: 17596594
Curr Pharm Des. 2007;13(12):1247-56
pubmed: 17504233
Int J Mol Sci. 2016 Jan 12;17(1):
pubmed: 26771606
Sarcoma. 2016;2016:4592768
pubmed: 27895527
J Exp Clin Cancer Res. 2017 Jun 9;36(1):77
pubmed: 28599664
Biochem Biophys Res Commun. 2012 Aug 10;424(4):663-8
pubmed: 22776205
Immunity. 2013 Feb 21;38(2):296-308
pubmed: 23333075
Mediators Inflamm. 2009;2009:752406
pubmed: 19390623
Eur J Cardiothorac Surg. 2005 Oct;28(4):617-21
pubmed: 16125954
Lab Invest. 2007 Feb;87(2):189-98
pubmed: 17318197
Int J Cancer. 1999 May 31;81(5):761-6
pubmed: 10328230
Am J Pathol. 2001 May;158(5):1743-56
pubmed: 11337372
Oncol Lett. 2018 Apr;15(4):5859-5864
pubmed: 29552215
Cancer Biol Ther. 2010 Feb;9(4):277-85
pubmed: 20026904
J Immunother Cancer. 2018 Sep 12;6(1):88
pubmed: 30208943
Pharmacol Rev. 2000 Sep;52(3):415-72
pubmed: 10977869
Chest. 2019 Oct;156(4):706-714
pubmed: 31047956
Lung Cancer Int. 2017;2017:6914976
pubmed: 28791183
Sci Rep. 2017 Oct 16;7(1):13293
pubmed: 29038523
Cancer Genet Cytogenet. 2004 Nov;155(1):42-6
pubmed: 15527901
Int J Clin Exp Med. 2015 Aug 15;8(8):12656-60
pubmed: 26550179
Pharmacol Ther. 2013 May;138(2):285-93
pubmed: 23384596
Medicine (Baltimore). 2015 Jun;94(22):e887
pubmed: 26039117
Pulm Pharmacol Ther. 2019 Oct;58:101833
pubmed: 31376462
Ther Adv Med Oncol. 2018 May 04;10:1758835918772810
pubmed: 29774061
Oncol Rep. 2011 Nov;26(5):1157-64
pubmed: 21769437
Respir Res. 2004 Nov 30;5:24
pubmed: 15571627
Antioxid Redox Signal. 2015 Jan 20;22(3):241-58
pubmed: 25089563
Cancer Res. 2012 Apr 15;72(8):2057-67
pubmed: 22389453
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
J Endocrinol. 2002 May;173(2):305-13
pubmed: 12010638
Lung Cancer Int. 2014;2014:721087
pubmed: 26316944
Cancer Lett. 2015 Jun 1;361(2):174-84
pubmed: 25766658
J Pathol. 2019 Apr;247(5):589-605
pubmed: 30680732
Int J Cancer. 2008 May 15;122(10):2249-54
pubmed: 18241037
J Am Soc Nephrol. 2012 Jul;23(7):1181-9
pubmed: 22518004
Cancer Lett. 2013 Nov 28;341(1):97-104
pubmed: 23089245
J Immunol. 2012 Jan 1;188(1):21-8
pubmed: 22187483
Clin Chim Acta. 2006 May;367(1-2):170-4
pubmed: 16458281
Cancer Commun (Lond). 2019 Jul 15;39(1):43
pubmed: 31307548
Int J Cancer. 2014 Jan 1;134(1):32-42
pubmed: 23784932
Nat Rev Nephrol. 2018 May;14(5):325-336
pubmed: 29578208
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L631-40
pubmed: 19592460
Int J Oncol. 2012 Aug;41(2):573-82
pubmed: 22664794
Sci Rep. 2017 Oct 30;7(1):14300
pubmed: 29085026
Cell. 2007 Nov 2;131(3):463-75
pubmed: 17981115
Eur Respir J. 2012 Jan;39(1):141-8
pubmed: 21659414
J Cell Physiol. 2003 Aug;196(2):370-7
pubmed: 12811831
Cancers (Basel). 2019 Sep 03;11(9):
pubmed: 31484460
Fibrogenesis Tissue Repair. 2015 Apr 23;8:7
pubmed: 25949522
Oncol Rep. 2012 Mar;27(3):783-90
pubmed: 22089256
Nat Rev Immunol. 2010 Sep;10(9):645-56
pubmed: 20725108
Ann N Y Acad Sci. 2008 Sep;1138:65-72
pubmed: 18837885
Life Sci. 1996;58(7):591-7
pubmed: 8632712
Am J Clin Oncol. 2018 Apr;41(4):396-401
pubmed: 27100959
Cell Physiol Biochem. 2015;37(3):1210-8
pubmed: 26418253

Auteurs

Maria Joana Catarata (MJ)

Tumour & Microenvironment Interactions Group, I3S-Institute for Health Research & Innovation, University of Porto, 4200-135 Porto, Portugal.
Tumour & Microenvironment Interactions Group, INEB-Biomedical Engineering Institute, University of Porto, 4200-135 Porto, Portugal.
Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.
Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Molecular Oncology and Viral Pathology Group-Research Centre, Portuguese Institute of Oncology, 4200-072 Porto, Portugal.

Ricardo Ribeiro (R)

Tumour & Microenvironment Interactions Group, I3S-Institute for Health Research & Innovation, University of Porto, 4200-135 Porto, Portugal.
Tumour & Microenvironment Interactions Group, INEB-Biomedical Engineering Institute, University of Porto, 4200-135 Porto, Portugal.
Laboratory of Genetics, Faculty of Medicine, University of Lisbon, 1649-028 Lisboa, Portugal.
Department of Clinical Pathology, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.

Maria José Oliveira (MJ)

Tumour & Microenvironment Interactions Group, I3S-Institute for Health Research & Innovation, University of Porto, 4200-135 Porto, Portugal.
Tumour & Microenvironment Interactions Group, INEB-Biomedical Engineering Institute, University of Porto, 4200-135 Porto, Portugal.
Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.

Carlos Robalo Cordeiro (C)

Department of Pulmonology, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.
Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.

Rui Medeiros (R)

Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Molecular Oncology and Viral Pathology Group-Research Centre, Portuguese Institute of Oncology, 4200-072 Porto, Portugal.

Classifications MeSH